Fingerprint
Dive into the research topics of 'North Central Cancer Treatment Group (NCCTG) N0432: Phase II trial of docetaxel with capecitabine and bevacizumab as first-line chemotherapy for patients with metastatic breast cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically